Tulyp Medical has emerged from stealth with its pressure-driven perfusion system for vascular procedures and submitted a 510(k) application with the US Food and Drug Administration (FDA) for the technology.

Borne out of Sofinnova Partners’ medtech accelerator, Sofinnova MD Start, the France-based medical device company’s system is designed for the oxygenation of tissue that may otherwise be obstructed and lead to complications including amputations or death.